Department of Public Health

Medicine & Life Sciences

1. HIV 100%
2. Visceral Leishmaniasis 92%
3. Health 83%
4. Democratic Republic of the Congo 69%
5. Malaria 59%
6. Ethiopia 44%
7. Netherlands 42%
8. Uganda 41%
9. Income 40%
10. Tuberculosis 36%
11. India 35%
12. Gambia 35%
13. Africa South of the Sahara 34%
14. Guinea 33%
15. Cross-Sectional Studies 33%
16. Cambodia 32%
17. Nepal 30%
18. Delivery of Health Care 30%
19. Health Facilities 29%
20. Sexually Transmitted Diseases 28%
21. Burkina Faso 28%
22. Leishmania donovani 28%
23. Pre-Exposure Prophylaxis 28%
24. Primary Health Care 28%
25. Public Health 27%
26. Belgium 27%
27. Health Services 27%
28. Sexual and Gender Minorities 27%
29. Infection 26%
30. Pandemics 25%
31. Population 24%
32. Therapeutics 23%
33. Leishmaniasis 22%
34. Interviews 22%
35. Morocco 21%
36. Child 21%
37. Human Influenza 19%
38. Disease Outbreaks 19%
39. Kenya 18%
40. African Trypanosomiasis 18%
41. Incidence 18%
42. Referral and Consultation 18%
43. HIV Infections 17%
44. Systematic Reviews 17%
45. Cohort Studies 17%
46. Health Personnel 17%
47. Sex Workers 17%
48. Organizations 16%
49. South Africa 16%
50. Epidemics 16%
51. Costs and Cost Analysis 16%
52. Insecticides 16%
53. Prenatal Care 16%
54. Mothers 16%
55. Acquired Immunodeficiency Syndrome 15%
56. Quality of Health Care 15%
57. Vaccination 15%
58. Pregnancy 15%
59. Parasites 15%
60. Routine Diagnostic Tests 14%
61. Pregnant Women 14%
62. Randomized Controlled Trials 14%
63. Tanzania 14%
64. Dengue 14%
65. Vietnam 14%
66. Global Health 14%
67. Western Africa 13%
68. Rwanda 13%
69. Obstetrics 13%
70. Mortality 13%
71. Benin 13%
72. Chlamydia 13%
73. Food 13%
74. Maternal Health 13%
75. Pharmaceutical Preparations 13%
76. Economics 13%
77. Bangladesh 12%
78. Health Policy 12%
79. Vaccines 12%
80. Confidence Intervals 12%
81. Contraceptive Agents 12%
82. Motivation 12%
83. Newborn Infant 12%
84. Parturition 12%
85. Lumefantrine Drug Combination Artemether 12%
86. Cuba 12%
87. Guidelines 12%
88. miltefosine 12%
89. Noncommunicable Diseases 11%
90. Sexual Health 11%
91. Zambia 11%
92. Reproductive Health 11%
93. Psychodidae 11%
94. Polymerase Chain Reaction 11%
95. Fees and Charges 11%
96. dihydroartemisinin 11%
97. Treatment Adherence and Compliance 11%
98. Odds Ratio 10%
99. Pulmonary Tuberculosis 10%